Penn Medicine and Wills Eye Hospital Pursue Partnership
The hospitals are negotiating a joint operating agreement after Wills Eye ended its long-standing affiliation with Jefferson.
Updated on Oct. 9, 2026 in Healthcare
Live Poll
Do you believe hospital partnerships and mergers are generally good for your local community?
Wills Eye Hospital and Penn Medicine have signed a preliminary joint operating agreement to explore a clinical and research partnership. The deal follows the end of a multi-decade affiliation between Wills Eye and Jefferson Health.
Why it matters
Wills Eye has struggled with sustained financial instability, reporting 11 consecutive years of operating losses. This potential shift signals a restructuring attempt aimed at addressing these deficits while integrating with a major health system.
Wills Eye Hospital reported an operating loss of $15.9 million on $109.8 million in total revenue for the fiscal year ending June 30, 2025. This result marks the institution's 11th consecutive year of operating losses.
The players
Wills Eye Hospital
A specialized ophthalmology institution in Philadelphia with an inpatient unit at 840 Walnut Street.
Penn Medicine
A major Philadelphia-based academic health system with a large clinical and research footprint.
Jefferson Health
An academic health system that recently ended its long-standing affiliation with Wills Eye.
Julia A. Haller
The CEO of Wills Eye Hospital who oversees its clinical operations and institutional strategy.
Robert Sergott
The interim chair of ophthalmology at Sidney Kimmel Medical College appointed by Jefferson Health.
The details
The hospitals are currently conducting due diligence to evaluate opportunities for collaboration across patient care, research, and education. While Wills Eye maintains a 4-bed inpatient unit at 840 Walnut Street, the structure of the joint operating agreement remains under negotiation. The partnership aims to determine if shared resources can expand patient access and accelerate medical training initiatives.
Timeline
Wills Eye Hospital was founded in 1832.
The hospital's affiliation with Thomas Jefferson University Hospital began in 1972.
The most recent fiscal year concluded on June 30, 2025.
CEO Julia A. Haller notified employees of the deal between October 6 and October 10, 2026.
Jefferson appointed a new interim department chair on October 8, 2026.
Market Landscape
This move signals a major shift in the Philadelphia ophthalmology market, departing from the 1972 affiliation between Wills Eye and Thomas Jefferson University Hospital. The deal reflects a broader trend of specialized centers seeking stronger health system backing to stabilize finances.
Operators in the regional medical space should monitor whether this partnership results in standardized service contracts or shifts in referral networks for specialty care. Watch for finalized terms regarding the 4-bed inpatient unit, as any changes in facility management could impact local procurement or vendor relationships.
The takeaway
Ongoing operating losses for over a decade suggest that specialized facilities require deep integration with larger health systems to ensure long-term viability. Business leaders should monitor the results of the due diligence process to see if the deal reaches a final, signed status.
Further reading
For context on sector trends, see Healthcare.
Source note: This article includes information reported by The Philadelphia Inquirer.
Live Poll
Do you believe hospital partnerships and mergers are generally good for your local community?
